Global Gene Transplant Market Growth (Status and Outlook) 2023-2029

Global Gene Transplant Market Growth (Status and Outlook) 2023-2029

Gene Transplant is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

LPI (LP Information)' newest research report, the “Gene Transplant Industry Forecast” looks at past sales and reviews total world Gene Transplant sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Transplant sales for 2023 through 2029. With Gene Transplant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Transplant industry.

This Insight Report provides a comprehensive analysis of the global Gene Transplant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Transplant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Transplant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Transplant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Transplant.

The global Gene Transplant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Gene Transplant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gene Transplant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gene Transplant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gene Transplant players cover Gilead (Kite Pharma), Amgen (BioVex), Novartis and Roche (Spark Therapeutics), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Transplant market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Ex Vivo
In Vivo

Segmentation by application
Cancer Diseases
Hematological Disease
Hereditary Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Gilead (Kite Pharma)
Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)

Please note: The report will take approximately 2 business days to prepare and deliver.